A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment ...
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
Tenpoint Therapeutics' treatment targets presbyopia, which causes close-up vision loss in aging adults. The company, whose ...
The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
Eye drops can provide tremendous itch relief, especially if your eyeballs are prone to dryness from cold, low-humidity winter air; age; or screen time. But not all eye soothers are the same, and after ...
Glaucoma impacts the vision of more than 3 million Americans, increasing the pressure in the eye, damaging the optic nerve and, if left untreated, causing permanent damage and vision loss. Until now, ...
In the United States, around 128 million people live with presbyopia, an age-related condition that causes farsightedness, rendering objects closer to you fuzzy and indistinct. It's fairly common, and ...
Please provide your email address to receive an email when new articles are posted on . Patients improved visual acuity across three concentrations of pilocarpine. Adverse events were mild and ...